A third of chronically ill adults don't tell their clinicians that they underuse medications due to cost

NewsGuard 100/100 Score

About one-third of chronically ill adults who underuse medications because of the costs associated with buying the drugs, never tell their health care practitioners, according to an article in the September 13 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

Patients concerned with out-of-pocket medication costs often limit their prescription drug use, according to background information in the article. Because chronically ill patients often take multiple medications, they are especially vulnerable to the strain from drug costs, the article states. The underuse of essential medications, including cholesterol-lowering medications, heart medications, asthma medications and antipsychotics, has been associated with increased emergency department visits, nursing home admissions, acute psychiatric hospitalizations, and a decrease in self-reported health status, according to the article.

John D. Piette, Ph.D., from the University of Michigan, Ann Arbor, and colleagues surveyed 660 chronically ill adults (average age, 62.6 years) nationwide who had reported underusing medication the year before due to cost. Of those surveyed, 16 percent were nonwhite, 64 percent had at most a high school education, and 30 percent had an annual household income of $20,000 or less.

Of those surveyed, two thirds never told a clinician (doctor or nurse) in advance that they intended to underuse their medication due to cost, and 35 percent of respondents never discussed the subject at all. Of respondents who did not tell a clinician, 66 percent reported that they had not been asked about their ability to pay for prescriptions. Seventy two percent of patients who talked with their clinicians about medication costs found the conversations to be helpful. However, 31 percent said their medications were never changed to a generic or less expensive replacement. Also, only 30 percent of patients were informed of programs that help pay drug costs, and fewer people were told where to purchase less expensive medication (28 percent).

“This study suggests that most patients who fail to alert clinicians about their medication cost problems are not asked about their ability to pay for their medication, and many perceive that clinicians are unwilling or unable to help them with this problem,” the authors write.

The researchers conclude: “As drug costs continue to escalate and the number of adults with chronic illnesses grows, it will be increasingly important for health care providers to take an active role in discussing patients’ medication cost problems and appropriate strategies for addressing them.”

http://archinte.ama-assn.org/


In an accompanying editorial, Alex D. Federman, M.D., M.P.H., of Mount Sinai School of Medicine, New York, states that “when doctors don’t ask and patients don’t tell, opportunities to help are missed and patients remain at risk for underusing medications and services.”

“The combination of greater cost sharing and higher prices for medical care will increasingly drive patients to forgo medications and other services,” Dr. Federman writes. “As the burdens of health care costs increase, physicians have a greater responsibility to direct patients to sources of assistance with health care costs when help is needed, and to select affordable therapies whenever possible.”

“Because cost remains a significant barrier to care for many adults, such as the uninsured and the low-income elderly population, major policy initiatives are needed to improve access to care for these vulnerable populations. Meanwhile, physicians should work to facilitate patients’ access to care using available resources. At a minimum, physicians can ask patients about problems they might have paying for health care,” writes Dr. Federman.

He concludes: “Ultimately, it is the responsibility of the physician to create an atmosphere in which patients can freely discuss matters that affect their health and health care, no matter what the cause.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients